Answers are grounded in this paper and cite their sources.
The revised 2014 AMSA scorecard, with its more stringent criteria for evaluating COI policies, assigned fewer As and more Bs and Cs than in years past. This was the first study to identify schools with COI policies stronger than those recommended in 2008 by the Association of American Medical Colleges. Developing more stringent COI policies should be helpful in reducing the influence of pharmaceutical and device industry marketing on both trainees and faculty in American medical schools.
No takes yet. Share an insight, caveat, or question.
Carlat et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: